Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma.

about

Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma.

Item

http://www.wikidata.org/entity/Q39974781

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma.

@en

Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma.

@nl

type

Item

label

Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma.

@en

Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma.

@nl

prefLabel

Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma.

@en

Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma.

@nl

P1476

Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma.

@en

P2093

Ferenc Magyari

http://www.w3.org/2001/XMLSchema#string

Kata Husi

http://www.w3.org/2001/XMLSchema#string

László Váróczy

http://www.w3.org/2001/XMLSchema#string

Miklós Udvardy

http://www.w3.org/2001/XMLSchema#string

Sándor Barna

http://www.w3.org/2001/XMLSchema#string

Zsófia Miltényi

http://www.w3.org/2001/XMLSchema#string

Zsófia Simon

http://www.w3.org/2001/XMLSchema#string

Árpád Illés

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma.

Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients.

Rituximab in Hodgkin lymphoma: is the target always a hit?

Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).

Bendamustine: rebirth of an old drug.

Treatment strategies for Hodgkin lymphoma recurring following autologous hematopoietic stem cell transplantation.

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma

Role of radiation therapy in Hodgkin's lymphoma.

Bendamustine: something old, something new.

Does rituximab have a place in treating classic hodgkin lymphoma?

P304

404-410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10245332.2015.1115192

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292589196

http://www.w3.org/2001/XMLSchema#string

P698

26907830

http://www.w3.org/2001/XMLSchema#string